XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.13

-0.5%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (7143)	9/3/1998 1:28:00 AM
From: Slugger	Read Replies (1) of 17367

<<If anyone at XOMA knew the unblinded data I would think one could tell a lot from just the mood of the person. Several people at XOMA know the total deaths in the trial. These people are blinded as to who received Neuprex and who received the placebo. If this were not correct the trial would not be blinded.>> If XOMA knows the total deaths then they probably know how well the trial is going. If historical data show that 20-30% of patients die from meningitis and data from the trial shows numbers of say 10% then XOMA could imply that the drug is working. If the trial data is close to historical data then XOMA execs are sweating right now. So there are people at XOMA who have an idea how well things are going. Which might answer the question, "why are we hiring all these new people?"

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next